Tomuzotuximab

• Target :

  Apoptosis|||EGFR

• Related Pathways :

  Tyrosine Kinase/Adaptors|||JAK/STAT signaling|||Angiogenesis|||Apoptosis

• Bioactivity :

  Tomuzotuximab, a fully human glycoengineered IgG1 monoclonal antibody targeting EGFR (Anti-Human EGFR Recombinant Antibody), exhibits anticancer effects [1].

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  1646321-00-7